Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM

Diabetes
B L VergèsJ M Brun

Abstract

Apolipoprotein A-IV (apoA-IV) might play an important role in lipoprotein metabolism, including modulation of triglyceride-rich lipoprotein catabolism, reverse cholesterol transport and cholesteryl ester transfer protein (CETP) activity. Increased apoA-IV levels have been reported in plasma from NIDDM patients. The aim of the present study was to look for a possible association between plasma apoA-IV level and prevalence of macrovascular disease in NIDDM. One hundred and thirty-six NIDDM patients were studied (71 men, 65 women). Macrovascular disease was assessed in each patient by a standardized questionnaire, physical examination, resting electrocardiogram (ECG), and laboratory evaluation (ankle/arm blood pressure ratio, continuous wave Doppler velocimetry). Moreover, patients without any history of coronary heart disease and showing a normal resting ECG underwent a bicycle exercise test or a dipyridamole thallium scintigraphy to detect possible silent myocardial ischemia. Among the 136 NIDDM patients, 56 had macrovascular disease. ApoA-IV levels were significantly higher in NIDDM patients with macrovascular disease than in NIDDM patients without macrovascular disease (20.9 +/- 8.6 vs. 13.3 +/- 5.3 mg/dl; P < 0.001). The infl...Continue Reading

Citations

Sep 15, 2000·Journal of the American College of Cardiology·F KronenbergH Dieplinger
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·S X CaoS R Spindler
Mar 25, 2005·Journal of the American Society of Nephrology : JASN·Gregory C ShearerGeorge A Kaysen
Aug 3, 2006·Journal of Periodontology·Brian L MealeyUNKNOWN American Academy of Periodontology
Dec 29, 2004·Physiology & Behavior·Patrick Tso, Min Liu
Aug 17, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·T DoiP Tso
Nov 12, 2003·Experimental Biology and Medicine·Min LiuPatrick Tso
Jan 24, 2002·Journal of the American Society of Nephrology : JASN·Florian KronenbergArnold von Eckardstein
Jan 3, 2001·Journal of the American Society of Nephrology : JASN·Giovanni CandianoGian Marco Ghiggeri
May 26, 2004·Physiology & Behavior·Patrick Tso, Min Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.